COVID-19 nasal spray vaccine offers the first line of defense against virus
15/06/2023
Promising Results in Phase I Trial of Sodium Zirconium Cyclosilicate Offer New Treatment Option for Chinese Patients
16/12/2022
× CLOSE
Promising Results in Phase I Trial of Sodium Zirconium Cyclosilicate Offer New Treatment Option for Chinese Patients
16/12/2022
New drug offers hope of ‘functional cure’ for hepatitis B patients
06/12/2022
Phase 1 Study Shows Synergistic Anti-tumour Efficacy of Combination of New Drug and Chemotherapy for HCC, Warranting Further Phase II/III Studies
11/04/2022
× CLOSE
Phase 1 Study Shows Synergistic Anti-tumour Efficacy of Combination of New Drug and Chemotherapy for HCC, Warranting Further Phase II/III Studies
11/04/2022
Phase 1 Study Proves Long-acting Formulation of Bupivacaine a Safe Means to Relieve Post-surgical Pain
29/09/2021
× CLOSE
Phase 1 Study Proves Long-acting Formulation of Bupivacaine a Safe Means to Relieve Post-surgical Pain
29/09/2021
[HKU-CTC Public Education Series] Chapter 3: The Importance of Phase 1 Clinical Trials
17/09/2021
× CLOSE
[HKU-CTC Public Education Series] Chapter 3: The Importance of Phase 1 Clinical Trials
17/09/2021
A new chapter of HKU-CTC Public Education Series named “The Importance of Phase 1 Clinical Trials” was posted on HKU-CTC Facebook page on September 17, 2021.
Natural phytosterols prove to lower the low-density lipoprotein level and may reduce the risk of heart disease
24/05/2021
× CLOSE
Natural phytosterols prove to lower the low-density lipoprotein level and may reduce the risk of heart disease
24/05/2021
High cholesterol level is prevalent in Hong Kong. About half of the population have hypercholesterolemia. It is one of the major risk factor for cardiovascular diseases. Professor Bernard Cheung of HKU Department of Medicine and Dr. Ching-Lung Cheung of HKU Department of Pharmacy and Pharmacology conducted a 3-week clinical trial in 2015.